Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The proteasome is a large, multi-subunit protease complex that plays a central role in regulated protein degradation within eukaryotic cells. It is essential for maintaining cellular homeostasis by selectively degrading damaged, misfolded, or regulatory proteins that have been tagged with ubiquitin. The 26S proteasome, composed of the 20S core particle and 19S regulatory particle, is responsible for ATP-dependent degradation of polyubiquitinated proteins, regulating various cellular processes including cell cycle, apoptosis, and immune surveillance. Dysregulation or inhibition of proteasomal activity is clinically relevant, particularly in cancer therapy, where proteasome inhibitors are used to induce apoptosis in malignant cells.
Inhibition of proteasome-mediated protein degradation, leading to accumulation of pro-apoptotic factors and cell death.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome Complex (26S Proteasome).